medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2013, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2013; 60 (2)

Characterization of the metabolic syndrome in patients of the province of Santiago de Cuba, 2010

Araujo DY, Roque RC, Escobar CE, Marcel EA

Language: Spanish
References: 17
Page: 96-101
PDF size: 89.13 Kb.


ABSTRACT

Introduction: Metabolic syndrome represents a constellation of lipid risk factors and non lipid leading to the onset of cardiovascular disease, stroke, diabetes mellitus with implications on morbidity and mortality of these patients. Objective: To evaluate the behavior of metabolic syndrome in a group of randomly selected patients. Method: A descriptive study aimed at understanding the behavior of the metabolic syndrome in 129 patients attending the outpatient area of the Central Clinical Laboratory, General Hospital Dr. “Juan Bruno Zayas Alfonso” the city of Santiago de Cuba in the province of the same name in the period from January to June 2010. Results: A high percentage of the population studied was associated with the presence of cardiovascular risk factors with low HDL-C values ​​in both male and female, 82.9% and 89.5% respectively, higher triglyceride, 81.6 % in females and 74.3% in males and over 50% of patients of both sexes expressed high levels of blood pressure both systolic and diastolic. There was a higher prevalence of metabolic syndrome in men with 63.6% of all male patients, in relation to women who also showed a high percentage (51.4%) in their prevalence.
Conclusions: The association of risk factors that predominated in patients with metabolic syndrome was hypertriglyceridemia, hypertension and low HDL cholesterol. These results indicate that interventions should be undertaken and programs to encourage healthier lifestyle changes and preventive treatments that prevent the development of complications.


REFERENCES

  1. Valenciaga JL .Acercamiento a una panorámica transcendente: el síndrome metabólico. Rev Cub Med Gen Integr. 2005; 21(1). Disponible en: http://scielo.sld.cu/pdf/mgi/v21n1-2/mgi181-205.pdf

  2. Ruiz AA, León Y, Burgos D, et al. Alteraciones del metabolismo lipídico en adultos mayores de 60 años con enfermedades crónica no transmisible. Rev Mex Patol Clin. 2009 Ene- Marzo; 56(1):35 – 44. Disponible en: http://www.medigraphic.com/pdfs/patol/pt-2009/pt091f.pdf

  3. Definición mundial de consenso para el síndrome metabólico: Rev Panam Salud Pública. 2005; 18 (2).

  4. Tosta de Almeida R, Guimarães de Almeida MM, Araújo TM. Obesidad abdominal y riesgo cardiovascular: desempeño de indicadores antropométricos en mujeres. Arq Bras Cardiol. 2009; 92 (5): 375-380.

  5. Pedroso WR, Castillo M, Bonneau GA, Castro C, Cevallos B, Sánchez RA. Factores de Riesgo aterogénico en empleados públicos hospitalarios. Rev Fed Arg Cardiol. 2008; 37: 230–237.

  6. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA 2001; 285: 2486-2497.

  7. Pedroso W, Castillo M, Bonneau G. Síndrome metabólico y factores de riesgo asociados con el estilo de vida de adolescentes de una ciudad de Argentina, 2005. Rev Panam Salud Pública. 2008; (3): 149-160.

  8. Ramos RG, Orden K. The Prevalence of Metabolic Syndrome Among vs Women of childbearing age. Am J Pub Health. 2008; 98 (6): 1122–1127.

  9. Aguilar Z, García L. Tamiz para el síndrome metabólico en la perimenopausia. Rev Mex Ginecol Obstet. 2009; 77 (3): 123-127. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2009/gom093b.pdf

  10. López A, González J, Beltrán M, Alwakil M, Saucedo JM, Bascuñana A et al. Prevalencia de obesidad, diabetes, hipertensión, hipercolesterolemia y síndrome metabólico en adultos mayores de 50 años de Sanlúcar de Barrameda. Rev Esp Cardiol. 2008; 61 (11): 1150–1158.

  11. Velásquez G, Gazzinelli A, Correa R, Pimenta AM, Kac G. Prevalence of metabolic syndrome in a rural area of Brazil. Sao Paulo Med. 2007; 125 (3): 155-162.

  12. Badimóm JJ, Ibañez B. Incremento de la HDL como arma terapéutica en la aterotrombosis. Rev Esp Cardiol. 2010; 63 (3): 323–333.

  13. Harrington DM. Receptores de estrógenos polimorfismo y efectos del reemplazo de estrógenos sobre las lipoproteínas de alta densidad en mujeres con enfermedades coronarias. Rev Chil Obstet Ginecol. 2002; 67 (1).

  14. Levalle O, et al. Andrógenos y Síndrome Metabólico. Rev Argent Endoc Metab. 2007; 44(1): 39-41.

  15. Gutiérrez JJ, López J. Prevalencia del síndrome metabólico en la población laboral. El corazón de Asepeyo. An Med Interna. 2008; 25 (7): 325-330.

  16. Velasco RM, Jiménez A, Higuera F, Domínguez E, Bacardí M. Obesidad y resistencia a la insulina en adolescentes de Chiapas. Nutr Hosp. 2009; 24 (2): 187-192.

  17. Fernández MD, Albear QF. Caracterización fenotípica y metabólica del síndrome metabólico en Cartagena de Indias. Rev Colomb Cardiol. 2008; 15 (3): 97-91.c




2020     |     www.medigraphic.com